COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial. Abbasi J. JAMA 2022;327:115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abbasi J. COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial. JAMA 2022;327:115.
PMID: 35015052